Clinical Trials Directory

Trials / Completed

CompletedNCT01519063

Naltrexone and Memantine Effects on Alcohol Drinking Behaviors

Glutamate-opioid Interactions in Alcohol Drinking Behaviors

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the combined effects of the study medications naltrexone and memantine on alcohol drinking behaviors.

Detailed description

Participants will be randomized to receive a combination of naltrexone/memantine over a one week period and then participate in a laboratory session. During this session, participants are given an initial drink of alcohol followed by the choice to drink up to 12 more drinks over a three-hour period. These medications are hypothesized to reduce craving and number of drinks consumed prior to and after exposure to the initial drink of alcohol and during the three hour drinking period.

Conditions

Interventions

TypeNameDescription
DRUGNaltrexone and memantine firstNaltrexone 50mg memantine 20mg
DRUGNaltrexone and Placebo firstNaltrexone 50 mg Placebo

Timeline

Start date
2012-01-01
Primary completion
2017-03-29
Completion
2017-05-01
First posted
2012-01-26
Last updated
2020-03-09
Results posted
2019-07-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01519063. Inclusion in this directory is not an endorsement.

Naltrexone and Memantine Effects on Alcohol Drinking Behaviors (NCT01519063) · Clinical Trials Directory